Eglucent 100Iu/ ml Catg Injection 3 ml contains human insulin used to treat type 1 and type 2 diabetes mellitus. Diabetes mellitus is a condition that affects how the body processes glucose. In Diabetes Mellitus Type 1, the body does not produce enough insulin to regulate blood sugar levels. On the other hand, in Diabetes Mellitus type 2, either the body stops producing enough insulin (a hormone that helps lower blood sugar levels), or there is resistance to insulin action.

Eglucent 100Iu/ ml Catg Injection 3 ml works similarly to the insulin produced by the body. Eglucent 100Iu/ ml Catg Injection 3 ml stops the liver from producing more sugar and also helps move the sugar from the blood into other body tissues where it can be used for energy. Thereby, Eglucent 100Iu/ ml Catg Injection 3 ml helps control blood sugar levels.

Your doctor will advise you on how to use Eglucent 100Iu/ ml Catg Injection 3 ml. In some cases, you may experience injection site reactions like redness or swelling. You may also experience symptoms of hypoglycaemia and low blood sugar) such as cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, drowsiness, excessive hunger, temporary vision changes, headache, nausea, and palpitation (very high heartbeat). Most of these side effects of Eglucent 100Iu/ ml Catg Injection 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking Eglucent 100Iu/ ml Catg Injection 3 ml on your own as it may increase blood sugar levels. Do not take the Eglucent 100Iu/ ml Catg Injection 3 ml if you have low blood glucose levels, kidney, liver, or heart problems. Along with the Eglucent 100Iu/ ml Catg Injection 3 ml, you should take a healthy diet, exercise regularly, and maintain weight as your doctor advises. Eglucent 100Iu/ ml Catg Injection 3 ml is a cold chain medicine, so it must be stored in the refrigerator between 2-8 degrees Celsius; otherwise, its efficiency might decrease. Do not freeze.

Eglucent 100Iu/ ml Catg Injection 3 ml works by ensuring rapid and consistent sugar control. It facilitates the reuptake of sugar in muscle and fat cells and thus suppresses sugar production in the liver. It helps to decrease blood sugar levels after the intake of meals. It prevents the chances of developing serious complications of diabetes. Besides this, Eglucent 100Iu/ ml Catg Injection 3 ml can be safely prescribed during the pregnancy as well as lactation stage. Eglucent 100Iu/ ml Catg Injection 3 ml helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage of the retina (retinopathy), impairment of kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others.

• Hypoglycemia (low blood glucose levels)
• Injection site reactions (redness, swelling)

Eglucent 100Iu/ ml Catg Injection 3 ml is for subcutaneous use only and should never be administered intravenously (IV) or in the veins. Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients who are at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. Eglucent 100Iu/ ml Catg Injection 3 ml may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take Eglucent 100Iu/ ml Catg Injection 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems.

Drug-Drug Interactions: Eglucent 100Iu/ ml Catg Injection 3 ml may have an interaction with anti-depressants (phenelzine, iproniazid, isocarboxazid, nialamide, imipramine, desipramine, tranylcypromine, moclobemide), anti-Parkinson’s drug (selegiline), antibiotic (linezolid), (lithium, tryptophan), migraines drug (sumatriptan), pain killer (tramadol), anti-ulcer (cimetidine, lansoprazole, omeprazole), anti-fungal (fluconazole), anti-stroke pills (ticlopidine), blood-thinners (warfarin, dipyridamole, and phenprocoumon), antimalarial (mefloquine), heart-related drug (flecainide, propafenone), and medicines that decrease blood levels of potassium or magnesium, as these increase the risk of life-threatening heart rhythm disorder. Besides this, the use of oral antidiabetic pills like pramlintide acetate and antibiotics (pentamidine) may cause hypoglycaemia (low blood sugar level).

Drug-Food Interactions: Limit or avoid intake of alcoholic beverages with Eglucent 100Iu/ ml Catg Injection 3 ml as it may increase or decrease your blood sugar level.

Drug-Disease Interactions: Eglucent 100Iu/ ml Catg Injection 3 ml should not be given to patients with kidney disease, liver disease, low potassium level (hypokalaemia), and low blood sugar/glucose level (hypoglycaemia).

• PHENELZINE
• IPRONIAZID
• ISOCARBOXAZID
• NIALAMIDE
• IMIPRAMINE
• DESIPRAMINE
• TRANYLCYPROMINE
• MOCLOBEMIDE
• SELEGILINE
• LINEZOLID
• LITHIUM
• TRYPTOPHAN
• SUMATRIPTAN
• TRAMADOL
• CIMETIDINE
• LANSOPRAZOLE
• OMEPRAZOLE
• FLUCONAZOLE
• TICLOPIDINE
• WARFARIN
• DIPYRIDAMOLE
• PHENPROCOUMON
• MEFLOQUINE
• FLECAINIDE
• PROPAFENONE
• PENTAMIDINE

• Exercise may lower your body’s need for insulin during and for some time after the physical activity.
• Exercise may also speed up the effect of an insulin dose, especially if the exercise involves the area of injection site (for example, the leg should not be used for injection just prior to running).
• Discuss with your doctor how you should adjust your insulin regimen to accommodate exercise. 
• Avoid eating sugar food and prefer food cooked food low in calories.
• When travelling across more than 2 time zones, you should talk to your doctor concerning adjustments in your insulin schedule.

• You should normally inject Eglucent 100Iu/ ml Catg Injection 3 ml within 15 minutes of a meal.
• Always use a new sterile needle for each injection.

Diabetes: Diabetes is a chronic or lifelong disease that prevents the body from utilizing insulin properly. Insulin is the hormone that controls sugar levels in the blood. Diabetes is a condition in which blood glucose levels are above normal. It is of two types, namely: type-1 and type-2 diabetes. Type-1 diabetes is a condition in which the pancreas produces little or no insulin. Type-2 diabetes affects the way body processes the sugar. Symptoms of diabetes include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.